
doi: 10.1007/bf01810735
pmid: 2605346
One of the most exciting recent developments in cancer-related research has been the discovery and understanding of colony-stimulating factors. There is now a general optimism that these factors will be used in the treatment of a variety of solid tumors, lymphomas, and leukemias, as well as in the treatment of patients who are immunocompromised or undergoing bone marrow transplantation. We have gathered a distinguished panel of experts to discuss the current status of this rapidly moving field.
Acquired Immunodeficiency Syndrome, Transplantation, Neutropenia, Stem Cells, Antineoplastic Agents, Bacterial Infections, Colony-Stimulating Factors, Immune Tolerance, Animals, Humans, Forecasting
Acquired Immunodeficiency Syndrome, Transplantation, Neutropenia, Stem Cells, Antineoplastic Agents, Bacterial Infections, Colony-Stimulating Factors, Immune Tolerance, Animals, Humans, Forecasting
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
